tirzepatide shortage ends Lilly CEO says weight-loss drug to end 'very soon', Bloomberg News reports FDA Announces End of Tirzepatide

Weight loss is slower and more modest, but for patients primarily interested in metabolic and anti-inflammatory benefits, microdosing offers a cost-effective approach

Since safety data is limited, most experts recommend waiting until youre finished nursing or discussing safer alternatives with your provider

Telehealth firm Hims & Hers Health (HIMS.N), which offers compounded versions of Wegovy, declined to comment

* Hyperreflexia and clonus are often worse in the legs than the arms

(With off-label use, a drug is prescribed to treat a condition other than those its approved for.) As a result of its effectiveness in managing blood sugar and aiding weight loss, Mounjaro is in high demand